by Natasha Davie | Mar 5, 2013
When it comes to the cell therapy commercialization crunch there are some fundamental questions that need to be answered. Is your product going to be frozen or fresh? How will the product be administered? What is your dosing strategy? And the one that I’m going to...
by Michael May | Nov 19, 2012
James Till and Ernest McCulloch identified stem cells 50 years ago in Toronto, and their legacy is a vibrant community of scientists who are leaders in this field of research. But what does that mean in terms of producing products and therapies to heal and cure...
by Stacey Johnson | Oct 31, 2012
with Roshan Yoganathan and Lisa Willemse Are zombies real? And yes, we mean creepy, flesh-eating, run-for-the-hills zombies — not that state you find yourself in on a Monday morning before you’ve had a double espresso. Unless you’re a zombie yourself, it’s quite...
by Stacey Johnson | Sep 26, 2012
My grandmother, at 97, is excited about stem cell research because she sees the possibilities. Regenerative medicine IS an exciting field. It’s on the cutting edge of science and fans and critics alike debate its merits regularly in the press and in blogs. Every day,...
by Natasha Davie | Aug 16, 2012
The health-care landscape is changing: the previous model of the blockbuster pharmaceutical is being challenged by new therapies that have the potential to offer more effective treatments. In this new contribution to Signals Blog, I describe the present landscape for...
by Angela C. H. McDonald | Aug 13, 2012
It takes precision, focus and persistence to perfect the art of origami. So perhaps it is no accident that researchers have needed to apply the same skills to overcome challenges in siRNA delivery, right down to the folding. A couple of years ago, my fellow blogger...
Comments